Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma ; day:18 ; month:12 ; year:2020 ; pages:1-12
European journal of nuclear medicine and molecular imaging ; (18.12.2020), 1-12
- Urheber
-
Sachpekidis, Christos
Kopp-Schneider, Annette
Pan, Leyun
Papamichail, Dimitrios
Haberkorn, Uwe
Hassel, Jessica C.
Dimitrakopoulou-Strauss, Antonia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-020-05137-7
- URN
-
urn:nbn:de:101:1-2021012413341382284235
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sachpekidis, Christos
- Kopp-Schneider, Annette
- Pan, Leyun
- Papamichail, Dimitrios
- Haberkorn, Uwe
- Hassel, Jessica C.
- Dimitrakopoulou-Strauss, Antonia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Amelanotic melanoma detected by 18F-FDG PET-CT
18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
A dedicated paediatric [18F]FDG PET/CT dosage regimen
Risikostratifizierung des rezidivierenden Mammakarzinoms mittels integrierter [18F]FDG PET/CT
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings
Hypertrophic Pachymeningitis Presenting as “Eyebrows” Sign on 18F FDG PET/CT
18F- FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer
Amelanotic melanoma detected by 18F-FDG PET-CT
18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
A dedicated paediatric [18F]FDG PET/CT dosage regimen
Risikostratifizierung des rezidivierenden Mammakarzinoms mittels integrierter [18F]FDG PET/CT
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings
Hypertrophic Pachymeningitis Presenting as “Eyebrows” Sign on 18F FDG PET/CT
18F- FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer
Amelanotic melanoma detected by 18F-FDG PET-CT
18F-FDG PET-CT in Fitz-Hugh-Curtis Syndrome
A dedicated paediatric [18F]FDG PET/CT dosage regimen
Risikostratifizierung des rezidivierenden Mammakarzinoms mittels integrierter [18F]FDG PET/CT
SMARCA4-deficient thoracic tumor detected by [18F]FDG PET/CT
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT
Atypical Muscular Sarcoidosis Involvement Revealed by 18F-FDG PET/CT
18F-FDG PET/CT in therapy response assessment: oligometastatic colorectal cancer
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Primary mesenchymal tumors of the prostate:18F FDG PET/CT findings
Hypertrophic Pachymeningitis Presenting as “Eyebrows” Sign on 18F FDG PET/CT